Short communication: The cost-effectiveness of cutaneous leishmaniasis patient management during an epidemic in Chaparral, Colombia in 2004

Tropical Medicine and International Health

Volumn 12, Issue 12, 2007, Pages 1540-1544

  Vega, Juan Carlos ^a,b   Sanchez, Boris Fernando ^c   Montero, Luz Mery ^c   Montaña, Rafael ^c   Del Pilar Mahecha, Mercedes ^c   Dueñes, Bladimir ^c   Baron, Ángela Rocío ^c   Reithinger, Richard ^d,e,f,g  

^a UNIVERSIDAD MILITAR NUEVA GRANADA   (Colombia)

^b UNIVERSIDAD EL BOSQUE   (Colombia)

^c Hospital San Juan Bautista   (Colombia)

^d WESTAT   (United States)

^e LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^f GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

^g Clinical Trials Area   (United States)

Author keywords

Cost effectiveness analysis; Leishmaniasis; Prevention and control; Treatment

Indexed keywords

MEGLUMINE ANTIMONATE;

ANTIMONY; COST-BENEFIT ANALYSIS; DISABILITY; DISEASE CONTROL; DISEASE TREATMENT; EPIDEMIC; PROTOZOAN;

ARTICLE; COST EFFECTIVENESS ANALYSIS; EPIDEMIC; HUMAN; MAJOR CLINICAL STUDY; PATIENT CARE; SKIN LEISHMANIASIS;

ANTIPROTOZOAL AGENTS; COLOMBIA; COST-BENEFIT ANALYSIS; DISEASE OUTBREAKS; HOSPITAL COSTS; HUMANS; LEISHMANIASIS; MEGLUMINE; ORGANOMETALLIC COMPOUNDS;

COLUMBIA [MISSOURI]; MISSOURI; NORTH AMERICA; UNITED STATES;

EID: 36749032306     PISSN: 13602276     EISSN: 13653156     Source Type: Journal    
DOI: 10.1111/j.1365-3156.2007.01962.x     Document Type: Article

References (14)

1. Arana BA Mendoza CE, Rizzo NR Kroeger A (2001) Randomized, controlled, double-blind trial of topical treatment of cutaneous leishmaniasis with paromomycin plus methylbenzethonium chloride ointment in Guatemala. The American Journal of Tropical Medicine Hygiene 65, 466 470.
2. Barendregt JJ, Bonneux L Van der Maas PJ (1996) DALYs: the age-weights on balance. Bulletin World Health Organisation 74, 439 443.
3. Costa JM, Vale KC, Cecilio IN et al. (1987) Psychosocial and stigmatizing aspects of mucocutaneous leishmaniasis. Revista da Sociedade Brasileira de Medecina Tropical 20, 77 81.
4. Davies CR, Reithinger R, Campbell-Lendrum D, Feliciangeli D, Borges R Rodriguez N (2000) The epidemiology and control of leishmaniasis in Andean countries. Cadernos de Saúde Pública 16, 925 950.
5. Guthmann JP, Arlt D, Garcia LM et al. (2005) Control of mucocutaneous leishmaniasis, a neglected disease: results of a control programme in Satipo Province, Peru. Tropical Medicine International Health 10, 856 862.
6. Iglesias CP, Drummond MF, Rovira J NEVALAT Project Group (2005) Health-care decision-making processes in Latin America: problems and prospects for the use of economic evaluation. International Journal of Technology Assessment in Health Care 21, 1 14.
7. Johns B, Baltussen R Hutubessy R (2003) Programme costs in the economic evaluation of programme costs. Cost Effectiveness and Resource Allocation 1, 1.
8. Murray CJL Lopez AD (1996) The Global Burden of Disease: A Comprehensive Assessment of Mortality and Disability From Diseases, Injuries and Risk Factors In 1990 and Projected to 2020. Harvard University Press, Cambridge, Massachusetts.
9. Murray HW, Berman JD, Davies CR Saravia NG (2005) Advances in leishmaniasis. Lancet 366, 1561 1577.
10. Palacios R, Osorio LE, Grajalew LF Ochoa MT (2001) Treatment failure in children in a randomized clinical trial with 10 and 20 days of meglumine antimonate for cutaneous leishmaniasis due to Leishmania viannia species. The American Journal of Tropical Medicine Hygiene 64, 187 193.
11. Reithinger R Coleman PG (2007) Treating cutaneous leishmaniasis patients in Kabul, Afghanistan: cost-effectiveness of an operational programme in a complex emergency setting. BMC Infectious Diseases 7, 3.
12. Tan-Torres Edejer T, Baltussen R, Adam T et al. (eds 2003) WHO Guide to Cost-effectiveness Analysis. World Health Organization, Geneva, pp. 1 329.
13. U.S. Department of State. Background Note Colombia: Profile. Available at: http://www.state.gov/r/pa/ei/bgn. Accessed on 13 April 2007.
14. Velez I, Agudelo S, Hendrickx E et al. (1997) Inefficacy of allopurinol as monotherapy for Colombian cutaneous leishmaniasis. A randomized, controlled trial. Annals of Internal Medicine 126, 232 236.